Background The current study reported a case with a history of neuroradiculitis. Within 2
months of the COVID‐19 vaccine, critical Guillain‐Barre Syndrome (GBS) appeared after …

COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect - Matarneh -
2021 - Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to Article …

Objective: After the outbreak of the global pandemic caused by SARS-CoV-2 infection at the
end of the year 2019, it took one year to start vaccination against this infection with products …

Dear Editor, we would like to share ideas on the publication “Guillain-Barré Syndrome
Following the BNT162b2 mRNA COVID-19 Vaccine [1].” In order to advance our …

Methods We report two cases of GBS, after receiving the first dose of Astrazeneca COVID-19
vaccine. Results Cases description: First case of a 70 years old woman, presenting …

Background The COVID-19 vaccine-related Guillain–Barré syndrome (GBS) has been
described for both messenger-RNA vaccine and adenovirus-vectored types in a few cases …

Guillain–Barre syndrome (GBS) is a rare, autoimmune neurologic condition that is preceded
by an infection in most cases. Though gastrointestinal illness is the most common, a variety …

Abstract Introduction Cases of Guillain-Barré Syndrome (GBS) have been believed to be
associated with the novel COVID-19 infection, and also with the following vaccines …

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) started to evolve from cluster
of cases to spread around the world causing the Coronavirus disease 2019 (COVID-19) …

There have been increasing reports of Guillain–Barré syndrome (GBS), a rare but
debilitating neurological disease, occurring post-COVID-19 vaccination. However, the …